Citation Impact
Citing Papers
GEMME: A Simple and Fast Global Epistatic Model Predicting Mutational Effects
2019
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
gp340 Expressed on Human Genital Epithelia Binds HIV-1 Envelope Protein and Facilitates Viral Transmission
2007 StandoutNobel
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
2013
Inhibiting sexual transmission of HIV-1 infection
2003
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
2004 StandoutNature
Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor
2004 StandoutNobel
HIV DNA Integration
2012
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Dicer-TRBP Complex Formation Ensures Accurate Mammalian MicroRNA Biogenesis
2014 StandoutNobel
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
2013 Standout
Kinetic Analysis of the Mechanism and Specificity of Protein-disulfide Isomerase Using Fluorescence-quenched Peptides
1998 StandoutNobel
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase
1999
Alanine-scanning Mutations in the ;Primer Grip; of p66 HIV-1 Reverse Transcriptase Result in Selective Loss of RNA Priming Activity
1997
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Laboratory Diagnosis of HIV in Adults: A Review of Current Methods
2013
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
2010
Emtricitabine (FTC) for the treatment of HIV infection
2004
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
2002 StandoutNature
Loop-mediated isothermal amplification of DNA
2000 Standout
Identification of centerin: a novel human germinal center B cell-restricted serpin
2000
MX2 is an interferon-induced inhibitor of HIV-1 infection
2013 StandoutNatureNobel
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Myocarditis
2011 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
Role of Residues in the Tryptophan Repeat Motif for HIV-1 Reverse Transcriptase Dimerization
2003
Properties of strand displacement synthesis by moloney murine leukemia virus reverse transcriptase: mechanistic implications
1998
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Vaccinia virus immune evasion
1997
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Extreme Genetic Fragility of the HIV-1 Capsid
2013
Revealing the world of RNA interference
2004 StandoutNatureNobel
Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity
2015 StandoutNatureNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Genetic History of Hepatitis C Virus in Venezuela: High Diversity and Long Time of Evolution of HCV Genotype 2
2010
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
1998 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Interactions Between Protein Disulphide Isomerase and Peptides
1997
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors
2003
Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France
2011
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
2001 StandoutNobel
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5
2002 Nobel
Serpin Structure, Mechanism, and Function
2002 Standout
Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
2015
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
2004
Viruses.STRING: A Virus-Host Protein-Protein Interaction Database
2018
Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells
1996
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
1999 StandoutNobel
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Mutation Rates and Intrinsic Fidelity of Retroviral Reverse Transcriptases
2009
Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription
2000
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
1997 StandoutScienceNobel
Estimating the Rate of Intersubtype Recombination in Early HIV-1 Group M Strains
2012
Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89
1997
Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors
2000
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors
1996 StandoutNobel
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
1997 Standout
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
G Protein-Dependent CCR5 Signaling Is Not Required for Efficient Infection of Primary T Lymphocytes and Macrophages by R5 Human Immunodeficiency Virus Type 1 Isolates
2003
Poxviruses and Immune Evasion
2003
Role of Murine Leukemia Virus Reverse Transcriptase Deoxyribonucleoside Triphosphate-Binding Site in Retroviral Replication and In Vivo Fidelity
2000
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Template Boundary in a Yeast Telomerase Specified by RNA Structure
2000 StandoutScienceNobel
Lymphocyte-Mediated Cytotoxicity
2002
Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1
1998
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
The Multiple Functions of TRBP, at the Hub of Cell Responses to Viruses, Stress, and Cancer
2012
Signal Transduction through MAP Kinase Cascades
1998 Standout
Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference
2002
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compoundCCR5polymorphisms
2003
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection
2004
Works of Eric J. Arts being referenced
Enrichment of intersubtype HIV-1 recombinants in a dual infection system using HIV-1 strain-specific siRNAs
2011
Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains
2001
Involvement of C-terminal Structural Elements of Equine Infectious Anemia Virus Reverse Transcriptase in DNA Polymerase and Ribonuclease H Activities
1996
Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection
2010
DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity
1994
Restoration of tRNA -primed( )-Strand DNA Synthesis to an HIV-1 Reverse Transcriptase Mutant with Extended tRNAs
1996
Interaction of Retroviral Reverse Transcriptase with Template–Primer Duplexes during Replication
1997
Escape of HIV-1 from a Small Molecule CCR5 Inhibitor Is Not Associated with a Fitness Loss
2007
Effects of Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 in Cell-free Recombinant Reverse Transcriptase Assays
1995
Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response
2009
Analysis of primer extension and the first template switch during human immunodeficiency virus reverse transcription
1995
Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Early Events in Reverse Transcription
1996
Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
2010
HIV-1 Antiretroviral Drug Therapy
2012
Identifying the Important HIV-1 Recombination Breakpoints
2008
Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs
2000
Multiple Forms of tRNALys3in HIV-1
1996
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
2008
Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.
1994
Mechanisms Involved in Stimulation of Human Immunodeficiency Virus Type 1 Replication by Aminooxypentane RANTES
2001
The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
2009
HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
2007
3′-Azido-3′-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants
1998
Natural Variation in the V3 Crown of Human Immunodeficiency Virus Type 1 Affects Replicative Fitness and Entry Inhibitor Sensitivity
2007
Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C
2002
The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
1994
Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site
1996
Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription
1994
A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression
2000
In Vitro Intersubtype Recombinants of Human Immunodeficiency Virus Type 1: Comparison to Recent and Circulating In Vivo Recombinant Forms
2002
Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.
1995